BRTX — Biorestorative Therapies Balance Sheet
0.000.00%
Last trade - 00:00
- $8.46m
- -$2.59m
- $0.15m
- 16
- 22
- 30
- 12
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.002 | 3.06 | 21 | 14.7 | 11.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.032 | 0.017 | 0.005 | 0.016 | 0.019 |
Prepaid Expenses | |||||
Total Current Assets | 0.069 | 3.19 | 21.5 | 15.1 | 11.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.658 | 0.496 | 0.396 | 0.503 | 0.507 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1.47 | 4.35 | 22.5 | 16.4 | 12.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.7 | 1.04 | 0.364 | 0.44 | 1.06 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 14.2 | 5.68 | 0.857 | 0.603 | 1.06 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -12.8 | -1.33 | 21.6 | 15.8 | 11.5 |
Total Liabilities & Shareholders' Equity | 1.47 | 4.35 | 22.5 | 16.4 | 12.6 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |